Retraction Note: Decreased miR-154 expression and its clinical significance in human colorectal cancer

  • Yang Kai
  • Cheng Qiang
  • Pan Xinxin
  • Zhou Miaomiao
  • Lin KuailuEmail author
Open Access
Retraction Note

Retraction note: World J Surg Oncol

The Editor-in-Chief is retracting this article [1] due to overlap with the following articles (amongst others) [2, 3, 4, 5, 6].

None of the authors have responded to any correspondence from the Editor-in-Chief or publisher about this retraction.


  1. 1.
    Kai Y, Qiang C, Xinxin P, Miaomiao Z, Kuailu L. Decreased miR-154 expression and its clinical significance in human colorectal cancer. World J Surg Oncol. 2015;13:195.CrossRefGoogle Scholar
  2. 2.
    Zhu, et al. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Diagn Pathol. 2014;(9):198
  3. 3.
    Fo, et al. MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma. OncoTargets and Therapy. 2014;7
  4. 4.
    Tang M, et al. MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma. OncoTargets Therapy. 2013;6:833–8 Scholar
  5. 5.
    Ye, et al. miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal Cancer. Plos One. 2013. Scholar
  6. 6.
    Sun, et al. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma. Biomed Pharmacother. 2015;71:58–63 Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Yang Kai
    • 1
  • Cheng Qiang
    • 2
  • Pan Xinxin
    • 1
  • Zhou Miaomiao
    • 1
  • Lin Kuailu
    • 1
    Email author
  1. 1.Department of Surgical OncologyThe First Affiliated Hospital of Wenzhou Medical CollegeWenzhouChina
  2. 2.Department of neurologyHuai’an No. 2 HospitalHuai’anChina

Personalised recommendations